Search research articles
Contact Us
Filters
Showing results (91-100 of 149) with videos related to
Page
of 15
Sort By:
Journal of the American College of Cardiology
|
August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation
N R Every, C P Cannon, C Granger, et al.
The Pharmacogenomics Journal
|
June 26, 2002
The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists
D C Shields, A P Fitzgerald, P A O'Neill, et al.
The American Journal of Cardiology
|
August 15, 1996
Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial)
Y Birnbaum, R A Kloner, S Sclarovsky, et al.
American Heart Journal
|
March 1, 1996
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators
R C Becker, C P Cannon, R P Tracy, et al.
The American Journal of Cardiology
|
May 15, 1995
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials
C P Cannon, B Thompson, C H McCabe, et al.
Circulation
|
May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy
C M Gibson, J A de Lemos, S A Murphy, et al.
American Heart Journal
|
November 14, 1997
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A
M J Tanasijevic, C P Cannon, D R Wybenga, et al.
Journal of the American College of Cardiology
|
December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction
H V Anderson, C P Cannon, P H Stone, et al.
Circulation
|
January 1, 1995
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
R A Kloner, T Shook, K Przyklenk, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B
M J Tanasijevic, C P Cannon, E M Antman, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 149) with videos related to
Sort By:
Page
of 15
Journal of the American College of Cardiology
|
August 26, 1998
Influence of insurance type on the use of procedures, medications and hospital outcome in patients with unstable angina: results from the GUARANTEE Registry. Global Unstable Angina Registry and Treatment Evaluation
N R Every, C P Cannon, C Granger, et al.
The Pharmacogenomics Journal
|
June 26, 2002
The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists
D C Shields, A P Fitzgerald, P A O'Neill, et al.
The American Journal of Cardiology
|
August 15, 1996
Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial)
Y Birnbaum, R A Kloner, S Sclarovsky, et al.
American Heart Journal
|
March 1, 1996
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators
R C Becker, C P Cannon, R P Tracy, et al.
The American Journal of Cardiology
|
May 15, 1995
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials
C P Cannon, B Thompson, C H McCabe, et al.
Circulation
|
May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy
C M Gibson, J A de Lemos, S A Murphy, et al.
American Heart Journal
|
November 14, 1997
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A
M J Tanasijevic, C P Cannon, D R Wybenga, et al.
Journal of the American College of Cardiology
|
December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction
H V Anderson, C P Cannon, P H Stone, et al.
Circulation
|
January 1, 1995
Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning?
R A Kloner, T Shook, K Przyklenk, et al.
Journal of the American College of Cardiology
|
September 14, 1999
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B
M J Tanasijevic, C P Cannon, E M Antman, et al.
Page
of 15